Patients with SDHB mutation have a relatively high malignancy incidence, ranging from 30% to 41%, with renal cell carcinoma observed in up to 14% and gastrointestinal stromal tumors in 2% of these cases [104]. This evidence concerns the gene SDHB and renal cell carcinoma.